(JEMA) JPMorgan Emerging Markets - Overview
Etf: Equity, Securities, Futures, Notes
Dividends
| Dividend Yield | 3.01% |
| Yield on Cost 5y | 3.27% |
| Yield CAGR 5y | 18.92% |
| Payout Consistency | 96.8% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 18.9% |
| Relative Tail Risk | -1.01% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.85 |
| Alpha | 32.58 |
| Character TTM | |
|---|---|
| Beta | 0.759 |
| Beta Downside | 0.739 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.11% |
| CAGR/Max DD | 0.96 |
Description: JEMA JPMorgan Emerging Markets January 19, 2026
The JPMorgan Emerging Markets Equity Core ETF (BATS:JEMA) is designed to allocate at least 80% of its net assets to equity securities and equity-linked instruments that derive economic exposure to emerging-market issuers. Eligible holdings include common stocks, participation notes, structured notes, and other vehicles that replicate equity performance, while the fund may also employ exchange-traded futures to manage cash-flow efficiency.
Key data points (as of the most recent public filing) include an expense ratio of 0.45%, total assets under management of roughly $2.3 billion, and a top-five country weighting of ≈ 30% China, ≈ 25% India, and ≈ 15% Brazil. Sector exposure is tilted toward information technology (≈ 22%) and consumer discretionary (≈ 18%), reflecting the growth-oriented nature of many emerging economies. Primary macro drivers for JEMA’s performance are commodity price trends (especially metals and energy), USD-exchange-rate movements, and global interest-rate policy, all of which influence capital flows into emerging-market equities.
For a deeper quantitative breakdown of JEMA’s risk-adjusted returns and factor exposures, you might explore ValueRay’s analytics platform.
What is the price of JEMA shares?
Over the past week, the price has changed by +1.62%, over one month by +5.26%, over three months by +12.99% and over the past year by +45.01%.
Is JEMA a buy, sell or hold?
What are the forecasts/targets for the JEMA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 61.6 | 13.9% |
JEMA Fundamental Data Overview February 02, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.45b USD (1.45b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.45b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.45b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.71% (E(1.45b)/V(1.45b) * Re(8.71%) + (debt-free company))
Discount Rate = 8.71% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)